Our hypothesis that vemurafenib acts as a potent AhR antagonist is further supported by reporter gene analyses, showing that vemurafenib treatment inhibited both basal as well as BaP-induced activity of the AhR-dependent luciferase construct
Our hypothesis that vemurafenib acts as a potent AhR antagonist is further supported by reporter gene analyses, showing that vemurafenib treatment inhibited both basal as well as BaP-induced activity of…